Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SION compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
SION
Sionna Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
SION
Sionna Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
SION
1 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
—
▲
+4.80%
—
May 12 '26
±10.9%
▼
−10.90%
×1.00
Q1 FY26
—
▼
−7.17%
—
Nov 5 '25
—
▼
−1.57%
—
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
= implied
SION realized, solid
LLY realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
SION
Sionna Therapeutics, Inc.
Change
3.27
▼
−0.38%
· post 3.23
Mkt cap
$148.1M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,358.90
Closed
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 6 '26
SION
Sionna Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
3.27
▼
−0.38%
post 3.23
Price
1,360.90
▼
−0.28%
post 1,358.90
$148.1M
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
SION
3.27
▼
−0.38%
vs
LLY
1,360.90
▼
−0.28%
Closed
Nov 6 '26